Cheng, Y.; Chen, S.; Cao, D.; Cheng, H.; Chen, S.; Shu, Y.; Wang, Y.; Chen, Z.
Stachydrine Ameliorates Uterine Hypercontractility in Primary Dysmenorrhea by Targeting the COX-2/PGF2α Pathway. Curr. Issues Mol. Biol. 2025, 47, 961.
https://doi.org/10.3390/cimb47110961
AMA Style
Cheng Y, Chen S, Cao D, Cheng H, Chen S, Shu Y, Wang Y, Chen Z.
Stachydrine Ameliorates Uterine Hypercontractility in Primary Dysmenorrhea by Targeting the COX-2/PGF2α Pathway. Current Issues in Molecular Biology. 2025; 47(11):961.
https://doi.org/10.3390/cimb47110961
Chicago/Turabian Style
Cheng, Yongfeng, Shuo Chen, Dianjie Cao, Hairu Cheng, Siyuan Chen, Yi Shu, Yue Wang, and Zhiwu Chen.
2025. "Stachydrine Ameliorates Uterine Hypercontractility in Primary Dysmenorrhea by Targeting the COX-2/PGF2α Pathway" Current Issues in Molecular Biology 47, no. 11: 961.
https://doi.org/10.3390/cimb47110961
APA Style
Cheng, Y., Chen, S., Cao, D., Cheng, H., Chen, S., Shu, Y., Wang, Y., & Chen, Z.
(2025). Stachydrine Ameliorates Uterine Hypercontractility in Primary Dysmenorrhea by Targeting the COX-2/PGF2α Pathway. Current Issues in Molecular Biology, 47(11), 961.
https://doi.org/10.3390/cimb47110961
